Comparing aminoglycoside binding sites in bacterial ribosomal RNA and aminoglycoside modifying enzymes

Proteins: Structure, Function and Bioinformatics

Volumn 81, Issue 1, 2013, Pages 63-80

  Romanowska, Julia ^a,b   Reuter, Nathalie ^c   Trylska, Joanna ^d  

^a UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF WARSAW   (Poland)

Author keywords

16S ribosomal RNA A site; Aminoglycoside modifying enzymes; Aminoglycosides; Bacterial resistance; Molecular dynamics simulations

Indexed keywords

AMINOGLYCOSIDE; BACTERIAL RNA; KANAMYCIN A; NUCLEIC ACID; RIBOSOME RNA; WATER;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BINDING SITE; ENERGY; HYDROGEN BOND; MOLECULAR DYNAMICS; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON TRANSPORT; SIMULATION; STATIC ELECTRICITY; X RAY CRYSTALLOGRAPHY;

BACTERIAL PROTEINS; BINDING SITES; COMPUTER SIMULATION; ESCHERICHIA COLI; KANAMYCIN; MOLECULAR DYNAMICS SIMULATION; RNA, BACTERIAL; RNA, RIBOSOMAL; STATIC ELECTRICITY; THERMODYNAMICS; TRANSFERASES; WATER;

BACTERIA (MICROORGANISMS);

EID: 84871062858     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24163     Document Type: Article

References (103)

1. Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME. Do we still need the aminoglycosides? Int J Antimicrob Agent 2009; 33: 201-205.
2. Houghton JL, Green KD, Chen W, Garneau-Tsodikova S. The future of aminoglycosides: the end or renaissance? ChemBioChem 2010; 11: 880-902.
3. Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrugresistant and extensively drug-resistant tuberculosis. Lancet Infect Dis 2010; 10: 621-629.
4. Magnet S, Blanchard JS. Molecular insights into aminoglycoside action and resistance. Chem Rev 2005; 105: 477-498.
5. Tselika S, Konstantinidis TC, Synetos D. Two nucleotide substitutions in the A-site of yeast 18S rRNA affect translation and differentiate the interaction of ribosomes with aminoglycoside antibiotics. Biochimie 2008; 90: 908-917.
6. Kaul M, Pilch DS. Thermodynamics of aminoglycoside-rRNA recognition: the binding of neomycin-class aminoglycosides to the A site of 16S rRNA. Biochemistry 2002; 41: 7695-7706.
7. Doi Y, Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 2007; 45: 88-94.
8. De Stasio EA, Dahlberg AE. Effects of mutagenesis of a conserved base-paired site near the decoding region of Escherichia coli 16 S ribosomal RNA. J Mol Biol 1990; 212: 127-133.
9. Gregory ST, Dahlberg AE. Nonsense suppressor and antisuppressor mutations at the 1409-1491 base pair in the decoding region of Escherichia coli 16S rRNA. Nucleic Acids Res 1995; 23: 4234-4238.
10. Hobbie SN, Bruell C, Kalapala S, Akshay S, Schmidt S, Pfister P, Böttger EC. A genetic model to investigate drug-target interactions at the ribosomal decoding site. Biochimie 2006; 88: 1033-1043.
11. Recht MI, Douthwaite S, Dahlquist KD, Puglisi JD. Effect of mutations in the A site of 16 S rRNA on aminoglycoside antibiotic-ribosome interaction. J Mol Biol 1999; 286: 33-43.
12. Pfister P, Hobbie SN, Vicens Q, Böttger EC, Westhof E. The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures. ChemBioChem 2003; 4: 1078-1088.
13. Vaiana AC, Westhof E, Auffinger P. A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns. Biochimie 2006; 88: 1061-1073.
14. Romanowska J, Setny P, Trylska J. Molecular dynamics study of the ribosomal A-site. J Phys Chem B 2008; 112: 15227-15243.
15. Chen SY, Lin TH. A molecular dynamics study on binding recognition between several 4, 5 and 4, 6-linked aminoglycosides with A-site RNA. J Mol Recognit 2010; 23: 423-434.
16. Romanowska J, McCammon JA, Trylska J. Understanding the origins of bacterial resistance to aminoglycosides through molecular dynamics mutational study of the ribosomal A-site. PLoS Comput Biol 2011; 7: e1002099.
17. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Update 2010; 13: 151-171.
18. Llano-Sotelo B, Azucena EF, Kotra LP, Mobashery S, Chow CS. Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chem Biol 2002; 9: 455-463.
19. Vetting MW, S de Carvalho LP, Yu M, Hegde SS, Magnet S, Roderick SL, Blanchard JS. Structure and functions of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys 2005; 433: 212-226.
20. Daigle DM, McKay GA, Thompson PR, Wright GD. Aminoglycoside antibiotic phosphotransferases are also serine protein kinases. Chem Biol 1999; 6: 11-18.
21. Lombès T, Bégis G, Maurice F, Turcaud S, Lecourt T, Dardel F, Micouin L. NMR-guided fragment-based approach for the design of AAC(6′)-Ib ligands. ChemBioChem 2008; 9: 1368-1371.
22. Vetting MW, Park CH, Hegde SS, Jacoby GA, Hooper DC, Blanchard JS. Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6′)-Ib and its bifunctional, fluoroquinolone-active AAC(6′)-Ib-cr variant. Biochemistry 2008; 47: 9825-9835.
23. Green KD, Chen W, Garneau-Tsodikova S. Effects of altering aminoglycoside structures on bacterial resistance enzyme activities. Antimicrob Agents Chemother 2011; 55: 3207-3213.
24. Rather PN, Munayyer H, Mann PA, Hare RS, Miller GH, Shaw KJ. Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6′-N-acetyltransferase Ib and IIa proteins. J Bacteriol 1992; 174: 3196-3203.
25. Shmara A, Weinsetel N, Dery KJ, Chavideh R, Tolmasky ME. Systematic analysis of a conserved region of the aminoglycoside 6′-N-acetyltransferase type Ib. Antimicrob Agents Chemother 2001; 45: 3287-3292.
26. Casin I, Hanau-Berçot B, Podglajen I, Vahaboglu H, Collatz E. Salmonella enterica serovar Typhimurium bla(PER-1)-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6′-N-acetyltransferase of type Ib. Antimicrob Agents Chemother 2003; 47: 697-703.
27. Pourreza A, Witherspoon M, Fox J, Newmark J, Bui D, Tolmasky ME. Mutagenesis analysis of a conserved region involved in acetyl coenzyme A binding in the aminoglycoside 6′-N-acetyltransferase type Ib encoded by plasmid pJHCMW1. Antimicrob Agents Chemother 2005; 49: 2979-2982.
28. Burk DL, Ghuman N, Wybenga-Groot LE, Berghuis AM. X-ray structure of the AAC(6′)- Ii antibiotic resistance enzyme at 1.8 A resolution; examination of oligomeric arrangements in GNAT superfamily members. Protein Sci 2003; 12: 426-437.
29. Wu L, Serpersu EH. Deciphering interactions of the aminoglycoside phosphotransferase(3′)- IIIa with its ligands. Biopolymers 2009; 91: 801-809.
30. Thompson PR, Hughes DW, Wright GD. Mechanism of aminoglycoside 3′-phosphotransferase type IIIa: His188 is not a phosphate-accepting residue. Chem Biol 1996; 3: 747-755.
31. Boehr DD, Thompson PR, Wright GD. Molecular mechanism of aminoglycoside antibiotic kinase APH(3′)-IIIa: roles of conserved active site residues. J Biol Chem 2001; 276: 23929-23936.
32. Thompson PR, Boehr DD, Berghuis AM, Wright GD. Mechanism of aminoglycoside antibiotic kinase APH(3′)-IIIa: role of the nucleotide positioning loop. Biochemistry 2002; 41: 7001-7007.
33. Burk DL, Hon WC, Leung AK, Berghuis AM. Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase. Biochemistry 2001; 40: 8756-8764.
34. Fong DH, Berghuis AM. Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry. EMBO J 2002; 21: 2323-2331.
35. Norris AL, Serpersu EH. NMR detected hydrogen-deuterium exchange reveals differential dynamics of antibiotic- and nucleotide-bound aminoglycoside phosphotransferase 3′-IIIa. J Am Chem Soc 2009; 131: 8587-8594.
36. Cox JR, McKay GA, Wright GD, Serpersu EH. Arrangement of substrates at the active site of an aminoglycoside antibiotic 3′-phosphotransferase as determined by NMR. J Am Chem Soc 1996; 118: 1295-1301.
37. Cox JR, Serpersu EH. Biologically important conformations of aminoglycoside antibiotics bound to an aminoglycoside 3′-phosphotransferase as determined by transferred nuclear Overhauser effect spectroscopy. Biochemistry 1997; 36: 2353-2359.
38. Sakon J, Liao HH, Kanikula AM, Benning MM, Rayment I, Holden HM. Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-A resolution. Biochemistry 1993; 32: 11977-11984.
39. Revuelta J, Vacas T, Torrado M, Corzana F, Gonzalez C, Jiménez-Barbero J, Menendez M, Bastida A, Asensio JL. NMR-based analysis of aminoglycoside recognition by the resistance enzyme ANT(4′): the pattern of OH/NH3(+) substitution determines the preferred antibiotic binding mode and is critical for drug inactivation. J Am Chem Soc 2008; 130: 5086-5103.
40. Pedersen LC, Benning MM, Holden HM. Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase. Biochemistry 1995; 34: 13305-13311.
41. Vicens Q, Westhof E. Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures. Biopolymers 2003; 70: 42-57.
42. Cox JR, Ekman DR, DiGiammarino EL, Akal-Strader A, Serpersu EH. Aminoglycoside antibiotics bound to aminoglycoside-detoxifying enzymes and RNA adopt similar conformations. Cell Biochem Biophys 2000; 33: 297-308.
43. Serpersu EH, Cox JR, DiGiammarino EL, Mohler ML, Ekman DR, Akal-Strader A, Owston M. Conformations of antibiotics in active sites of aminoglycoside-detoxifying enzymes. Cell Biochem Biophys 2000; 33: 309-321.
44. Bastida A, Hidalgo A, Chiara JL, Torrado M, Corzana F, Pérez-Cañadillas JM, Groves P, Garcia-Junceda E, Gonzalez C, Jiménez-Barbero J, Asensio JL. Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance. J Am Chem Soc 2006; 128: 100-116.
45. Krishna V, Kumar KSV, Anishetty S, Pennathur G. Investigations on Domain Movements of N-Acetyltransferase in Nano Scale. J Nanosci Nanotechnol 2009; 9: 5493-5496.
46. Hu X, Norris AL, Baudry JY, Serpersu EH. Coenzyme-A binding to the aminoglycoside acetyltransferase (3)-IIIb increases conformational sampling of antibiotic binding site. Biochemistry 2011; 50: 10559-10565.
47. Vetting MW, Magnet S, Nieves E, Roderick SL, Blanchard JS. A bacterial acetyltransferase capable of regioselective N-acetylation of antibiotics and histones. Chem Biol 2004; 11: 565-573.
48. François B, Russell RJM, Murray JB, Aboul-Ela F, Masquida B, Vicens Q, Westhof E. Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res 2005; 33: 5677-5690.
49. Nurizzo D, Shewry SC, Perlin MH, Brown SA, Dholakia JN, Fuchs RL, Deva T, Baker EN, Smith CA. The crystal structure of aminoglycoside-3′-phosphotransferase-IIa, an enzyme responsible for antibiotic resistance. J Mol Biol 2003; 327: 491-506.
50. Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 2007; 35: W522-W525.
51. Li H, Robertson AD, Jensen JH. Very fast empirical prediction and rationalization of protein pKa values. Proteins 2005; 61: 704-721.
52. Castañeda CA, Fitch CA, Majumdar A, Khangulov V, Schlessman JL, García-Moreno BE. Molecular determinants of the pKa values of Asp and Glu residues in staphylococcal nuclease. Proteins 2009; 77: 570-588.
53. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983; 79: 926-935.
54. Case DA, Darden TA, Cheatham TE, III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Wang B, Hayik S, Roitberg A, Seabra G, Kolossváry I, Wong KF, Paesani F, Vanicek J, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA. Amber 11. San Francisco: University of California, San Francisco; 2010.
55. Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee T, Caldwell J, Wang J, Kollman P. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 2003; 24: 1999-2012.
56. Lee MC, Duan Y. Distinguish protein decoys by using a scoring function based on a new AMBER force field, short molecular dynamics simulations, and the generalized born solvent model. Proteins 2004; 55: 620-634.
57. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem 2004; 25: 1157-1174.
58. Bayly CI, Cieplak P, Cornell W, Kollman PA. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem 1993; 97: 10269-10280.
59. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian 03, Revision C.02. Wallingford, CT: Gaussian, Inc.; 2004.
60. Rassolov VA, Ratner MA, Pople JA, Redfern PC, Curtiss LA. 6-31G* basis set for third-row atoms. J Comput Chem 2001; 22: 976-984.
61. Corzana F, Cuesta I, Freire F, Revuelta J, Torrado M, Bastida A, Jiménez-Barbero J, Asensio JL. The pattern of distribution of amino groups modulates the structure and dynamics of natural aminoglycosides: implications for RNA recognition. J Am Chem Soc 2007; 129: 2849-2865.
62. Banáš P, Hollas D, Zgarbová M, Jurečka P, Orozco M, Cheatham, TEIII, Šponer J, Otyepka M. Performance of molecular mechanics force fields for RNA simulations: stability of UUCG and GNRA hairpins. J Chem Theory Comput 2010; 6: 3836-3849.
63. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kalé L, Schulten K. Scalable molecular dynamics with NAMD. J Comput Chem 2005; 26: 1781-802.
64. Baker NA, Bashford D, Case DA. Implicit solvent electrostatics in biomolecular simulation. In: New algorithms for macromolecular simulation, Vol. 49. Springer; 2006. pp 263-295.
65. Onufriev A, Case DA, Bashford D. Effective Born radii in the generalized Born approximation: the importance of being perfect. JComput Chem 2002; 23: 1297-1304.
66. Srinivasan J, Cheatham TE, III, Cieplak P, Kollman PA, Case DA. Continuum Solvent Studies of the Stability of DNA, RNA, and Phosphoramidate-DNA Helices. J Am Chem Soc 1998; 120: 9401-9409.
67. Lafont V, Schaefer M, Stote RH, Altschuh D, Dejaegere A. Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies "efficient amino acids." Proteins 2007; 67: 418-434.
68. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001; 98: 10037-10041.
69. Długosz M, Trylska J. Electrostatic similarity of proteins: application of three dimensional spherical harmonic decomposition. J Chem Phys 2008; 129: 015103.
70. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graphics 1996; 14: 33-38.
71. Romanowska J, Nowiński KS, Trylska J. Determining geometrically stable domains in molecular conformation sets. J Chem Theory Comput 2012; 8: 2588-2599.
72. Grant BJ, Gorfe AA, McCammon JA. Ras conformational switching: simulating nucleotide-dependent conformational transitions with accelerated molecular dynamics. PLoS Comput Biol 2009; 5: e1000325.
73. Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD. Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics 2006; 22: 2695-2696.
74. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
75. Schmitt S, Kuhn D, Klebe G. A new method to detect related function among proteins independent of sequence and fold homology. J Mol Biol 2002; 323: 387-406.
76. Kim C, Mobashery S. Phosphoryl transfer by aminoglycoside 3′-phosphotransferases and manifestation of antibiotic resistance. Top Curr Chem 2005; 33: 149-158.
77. Thompson PR, Schwartzenhauer J, Hughes DW, Berghuis AM, Wright GD. The COOH terminus of aminoglycoside phosphotransferase (3′)-IIIa is critical for antibiotic recognition and resistance. J Biol Chem 1999; 274: 30697-30706.
78. Vicens Q, Westhof E. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure 2001; 9: 647-658.
79. Boehr DD, Farley AR, Wright GD, Cox JR. Analysis of the pi-pi stacking interactions between the aminoglycoside antibiotic kinase APH(3′)-IIIa and its nucleotide ligands. Chem Biol 2002; 9: 1209-1217.
80. Stogios PJ, Shakya T, Evdokimova E, Savchenko A, Wright GD. Structure and function of APH(4)-Ia, a hygromycin B resistance enzyme. J Biol Chem 2011; 286: 1966-1975.
81. James LC, Roversi P, Tawfik DS. Antibody multispecificity mediated by conformational diversity. Science 2003; 299: 1362-1367.
82. Sherrill CD, Sumpter BG, Sinnokrot MO, Marshall MS, Hohenstein EG, Walker RC, Gould IR. Assessment of standard force field models against high-quality ab initio potential curves for prototypes of pi-pi, CH/pi, and SH/pi interactions. J Comput Chem 2009; 30: 2187-2193.
83. Fu CF, Tian SX. A Comparative Study for Molecular Dynamics Simulations of Liquid Benzene. J Chem Theory Comput 2011; 7: 2240-2252.
84. Vacas T, Corzana F, Jiménez-Osés G, González C, Gómez AM, Bastida A, Revuelta J, Asensio JL. Role of aromatic rings in the molecular recognition of aminoglycoside antibiotics: implications for drug design. J Am Chem Soc 2010; 132: 12074-12090.
85. Asensio JL, Hidalgo A, Bastida A, Torrado M, Corzana F, Chiara JL, García-Junceda E, Cañada J, Jiménez-Barbero J. A simple structural-based approach to prevent aminoglycoside inactivation by bacterial defense proteins. Conformational restriction provides effective protection against neomycin-B nucleotidylation by ANT4. J Am Chem Soc 2005; 127: 8278-8279.
86. Matesanz R, Diaz JF, Corzana F, Santana AG, Bastida A, Asensio JL. Multiple keys for a single lock: the unusual structural plasticity of the nucleotidyltransferase (4′)/kanamycin complex. Chemistry 2012; 18: 2875-2889.
87. Hanessian S, Pachamuthu K, Szychowski J, Giguère A, Swayze EE, Migawa MT, François B, Kondo J, Westhof E. Structure-based design, synthesis and A-site rRNA co-crystal complexes of novel amphiphilic aminoglycoside antibiotics with new binding modes: a synergistic hydrophobic effect against resistant bacteria. Bioorg Med Chem Lett 2010; 20: 7097-7101.
88. Szychowski J, Kondo J, Zahr O, Auclair K, Westhof E, Hanessian S, Keillor JW. Inhibition of aminoglycoside-deactivating enzymes APH(3′)-IIIa and AAC(6′)-Ii by amphiphilic paromomycin O2″-ether analogues. ChemMedChem 2011; 6: 1961-1966.
89. Gohlke H, Kiel C, Case DA. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the ras-raf and ras-ralGDS complexes. J Mol Biol 2003; 330: 891-913.
90. Cai Y, Schiffer Ca. Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV. J Chem Theory Comput 2010; 6: 1358-1368.
91. Desheng L, Jian G, Yuanhua C, Wei C, Huai Z, Mingjuan J. Molecular dynamics simulations and MM/GBSA methods to investigate binding mechanisms of aminomethylpyrimidine inhibitors with DPP-IV. Bioorg Med Chem Lett 2011; 21: 6630-6635.
92. Zhou J, Wang G, Zhang LH, Ye XS. Modifications of aminoglycoside antibiotics targeting RNA. Med Res Rev 2007; 27: 279-316.
93. Hotta K, Sunada A, Ikeda Y, Kondo S. Double stage activity in aminoglycoside antibiotics. J Antibiot 2000; 53: 1168-1174.
94. Shaul P, Green KD, Rutenberg R, Kramer M, Berkov-Zrihen Y, Breiner-Goldstein E, Garneau-Tsodikova S, Fridman M. Assessment of 6′- and 6″′-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance. Org Biomiol Chem 2011; 9: 4057-4063.
95. Kondo J, Pachamuthu K, François B, Szychowski J, Hanessian S, Westhof E. Crystal structure of the bacterial ribosomal decoding site complexed with a synthetic doubly functionalized paromomycin derivative: a new specific binding mode to an a-minor motif enhances in vitro antibacterial activity. ChemMedChem 2007; 2: 1631-1638.
96. Baussanne I, Bussière A, Halder S, Ganem-Elbaz C, Ouberai M, Riou M, Paris JM, Ennifar E, Mingeot-Leclercq MP, Décout JL. Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives. J Med Chem 2010; 53: 119-127.
97. Yan RB, Yuan M, Wu Y, You X, Ye XS. Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains. Bioorg Med Chem 2011; 19: 30-40.
98. Armstrong ES, Miller GH. Combating evolution with intelligent design: the neoglycoside ACHN-490. Curr Opin Microbiol 2010; 13: 565-573.
99. Pokrovskaya V, Belakhov V, Hainrichson M, Yaron S, Baasov T. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics. J Med Chem 2009; 52: 2243-2254.
100. Nudelman I, Rebibo-Sabbah A, Shallom-Shezifi D, Hainrichson M, Stahl I, Ben-Yosef T, Baasov T. Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations. Bioorg Med Chem Lett 2006; 16: 6310-6315.
101. Azucena EF, Mobashery S. Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition. Drug Resist Update 2001; 4: 106-117.
102. Boehr DD, Draker Ka, Koteva K, Bains M, Hancock RE, Wright GD. Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes. Chem Biol 2003; 10: 189-196.
103. Fong DH, Xiong B, Hwang J, Berghuis AM. Crystal structures of two aminoglycoside kinases bound with a eukaryotic protein kinase inhibitor. PLoS One 2011; 6: e19589.